MELOXICAM TABLETS
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency awarded delivery order SPE2DP26F9227 to DMS Pharmaceutical Group Inc on August 27, 2026, under the primary commercial items contract SPE2DX25D9900. This specific order, issued by the DLA Troop Support Medical Supply Chain FSA, is for the procurement of Meloxicam Tablets, identified by NSN 6505015413243 and PR 7018091003. The total value of the award is 45.00 dollars for one bottle of the medication. The order specifies a delivery date of August 27, 2026, with destination shipment instructions directed to the USS Zumwalt (DDG 1000). This transaction is part of a broader commercial items procurement framework established by the original contract effective April 2, 2025.
General Info
Contract Value
$45Place of Performance
Not specifiedSet-Aside
Awardee
DMS PHARMACEUTICAL GROUP INCAward Issued Date
Documents
(2)AI Contract Breakdown
Uniform Contract FormatContract not broken down yet
CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
